{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:04:03Z","timestamp":1792699443190,"version":"4.5.0"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01CX000501"],"award-info":[{"award-number":["I01CX000501"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0226486","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T18:08:41Z","timestamp":1578938921000},"page":"e0226486","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-9122","authenticated-orcid":true,"given":"Jos\u00e9 V.","family":"Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail A.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Schwindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Adson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Rittberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk S.","family":"Abuzzahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"issue":"Suppl 13","key":"pone.0226486.ref001","first-page":"23","article-title":"When at first you don't succeed: Sequential strategies for antidepressant nonresponders","volume":"58","author":"ME Thase","year":"1997","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 8","key":"pone.0226486.ref002","first-page":"17","article-title":"Prevalence and management of treatment-resistant depression","volume":"68","author":"CB Nemeroff","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"pone.0226486.ref003","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0006-3223(02)01670-0","article-title":"Is treatment-resistant depression a unique subtype of depression?","volume":"53","author":"A Fagiolini","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"11","key":"pone.0226486.ref004","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report","volume":"163","author":"AJ Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"7","key":"pone.0226486.ref005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/070674371405900702","article-title":"Treatment-resistant depression in primary care across Canada","volume":"59","author":"SJ Rizvi","year":"2014","journal-title":"Can J Psychiatry"},{"key":"pone.0226486.ref006","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.psychres.2016.04.034","article-title":"Socio-demographic and clinical predictors of non-response\/non-remission in treatment resistant depressed patients: A systematic review","volume":"240","author":"V De Carlo","year":"2016","journal-title":"Psychiatry Res"},{"issue":"11","key":"pone.0226486.ref007","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4088\/JCP.v64n1112","article-title":"Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder","volume":"64","author":"GI Papakostas","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"pone.0226486.ref008","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","article-title":"Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study","volume":"68","author":"D Souery","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"10053","key":"pone.0226486.ref009","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: A systematic analysis for the global burden of disease study 2015","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"pone.0226486.ref010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"HS Mayberg","year":"2005","journal-title":"Neuron"},{"issue":"6","key":"pone.0226486.ref011","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3171\/jns.2003.99.6.1010","article-title":"Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression","volume":"99","author":"DD Dougherty","year":"2003","journal-title":"J Neurosurg"},{"issue":"1","key":"pone.0226486.ref012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroimage.2004.01.015","article-title":"Limbic-frontal circuitry in major depression: A path modeling metanalysis","volume":"22","author":"DA Seminowicz","year":"2004","journal-title":"Neuroimage"},{"issue":"1\u20133","key":"pone.0226486.ref013","first-page":"219","article-title":"Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism","volume":"127","author":"CT Li","year":"2010","journal-title":"J Affect Disord"},{"issue":"4","key":"pone.0226486.ref014","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1192\/bjp.bp.113.140434","article-title":"Prefrontal glucose metabolism in medication-resistant major depression","volume":"206","author":"CT Li","year":"2015","journal-title":"Br J Psychiatry"},{"issue":"3","key":"pone.0226486.ref015","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/hbm.23085","article-title":"The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study","volume":"37","author":"CT Li","year":"2016","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"pone.0226486.ref016","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.brs.2012.11.006","article-title":"Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression","volume":"6","author":"CR Conway","year":"2013","journal-title":"Brain Stimul"},{"issue":"2","key":"pone.0226486.ref017","first-page":"57","article-title":"Functional neuroimaging in treatment-resistant depression. Depression","volume":"3","author":"JV Pardo","year":"2007","journal-title":"Mind and Body"},{"issue":"2","key":"pone.0226486.ref018","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.neuroimage.2008.04.267","article-title":"Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism","volume":"42","author":"JV Pardo","year":"2008","journal-title":"Neuroimage"},{"issue":"4","key":"pone.0226486.ref019","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1172\/JCI38454","article-title":"Targeted electrode-based modulation of neural circuits for depression","volume":"119","author":"HS Mayberg","year":"2009","journal-title":"J Clin Invest"},{"key":"pone.0226486.ref020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.2003.tb07098.x","article-title":"Neuroimaging abnormalities in the amygdala in mood disorders","volume":"985","author":"WC Drevets","year":"2006","journal-title":"Ann N Y Acad of Sci"},{"issue":"8","key":"pone.0226486.ref021","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S1092852900013754","article-title":"The subgenual anterior cingulate cortex in mood disorders","volume":"13","author":"WC Drevets","year":"2008","journal-title":"CNS Spectr"},{"issue":"6","key":"pone.0226486.ref022","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1176\/appi.ajp.158.6.899","article-title":"Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression","volume":"158","author":"SH Kennedy","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"8","key":"pone.0226486.ref023","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0006-3223(00)01036-2","article-title":"Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response","volume":"48","author":"HS Mayberg","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"8","key":"pone.0226486.ref024","doi-asserted-by":"crossref","first-page":"e70089","DOI":"10.1371\/journal.pone.0070089","article-title":"Impaired prefronto-thalamic functional connectivity as a key feature of treatment-resistant depression: A combined MEG, PET and rTMS study","volume":"8","author":"CT Li","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"pone.0226486.ref025","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1038\/s41598-018-23685-9","article-title":"Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorder","volume":"8","author":"B Cao","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0226486.ref026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jad.2018.08.026","article-title":"Habenular connectivity may predict treatment response in depressed psychiatric inpatients","volume":"242","author":"SN Gosnell","year":"2019","journal-title":"J Affect Disord"},{"issue":"11","key":"pone.0226486.ref027","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/mp.2008.57","article-title":"Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies","volume":"13","author":"JP Hamilton","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"1","key":"pone.0226486.ref028","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/s41598-019-46687-7","article-title":"Structural MRI at 7T reveals amygdala nuclei and hippocampal subfield volumetric association with major depressive disorder symptom severity","volume":"9","author":"SSG Brown","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0226486.ref029","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0006-3223(01)01263-X","article-title":"Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study","volume":"50","author":"YI Sheline","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"11","key":"pone.0226486.ref030","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archgenpsychiatry.2010.144","article-title":"Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder","volume":"67","author":"TA Victor","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"pone.0226486.ref031","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1176\/ajp.2006.163.4.735","article-title":"Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy","volume":"163","author":"GJ Siegle","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"9","key":"pone.0226486.ref032","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0006-3223(02)01314-8","article-title":"Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals","volume":"51","author":"GJ Siegle","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"10","key":"pone.0226486.ref033","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamapsychiatry.2014.1087","article-title":"Abnormal amygdala resting-state functional connectivity in adolescent depression","volume":"71","author":"KR Cullen","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"pone.0226486.ref034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fpsyt.2014.00017","article-title":"Reduced intrinsic connectivity of amygdala in adults with major depressive disorder","volume":"5","author":"R Ramasubbu","year":"2014","journal-title":"Front Psychiatry"},{"issue":"1","key":"pone.0226486.ref035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/acps.12724","article-title":"Insula and amygdala resting-state functional connectivity differentiate bipolar from unipolar depression","volume":"136","author":"E Ambrosi","year":"2017","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"pone.0226486.ref036","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1017\/S0033291712002759","article-title":"Decreased functional connectivity between the amygdala and the left ventral prefrontal cortex in treatment-naive patients with major depressive disorder: a resting-state functional magnetic resonance imaging study","volume":"43","author":"Y Tang","year":"2013","journal-title":"Psychol Med"},{"key":"pone.0226486.ref037","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2003.tb07070.x","article-title":"Comparative aspects of amygdala connectivity","volume":"985","author":"JL Price","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"pone.0226486.ref038","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.neuron.2013.11.006","article-title":"Long-range connectivity defines behavioral specificity of amygdala neurons","volume":"81","author":"V Senn","year":"2014","journal-title":"Neuron"},{"key":"pone.0226486.ref039","article-title":"Translating fear circuitry: Amygdala projections to subgenual and perigenual anterior cingulate in the macaque","author":"KK Sharma","year":"2019","journal-title":"Cereb Cortex"},{"issue":"6627","key":"pone.0226486.ref040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/386824a0","article-title":"Subgenual prefrontal cortex abnormalities in mood disorders","volume":"386","author":"WC Drevets","year":"1997","journal-title":"Nature"},{"issue":"9","key":"pone.0226486.ref041","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"G Rajkowska","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"4","key":"pone.0226486.ref042","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0006-3223(01)01280-X","article-title":"Volumetric reduction in left subgenual prefrontal cortex in early onset depression","volume":"51","author":"KN Botteron","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"5","key":"pone.0226486.ref043","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1176\/appi.ajp.159.5.728","article-title":"The functional neuroanatomy of the placebo effect","volume":"159","author":"HS Mayberg","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"2","key":"pone.0226486.ref044","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1176\/appi.ajp.158.2.305","article-title":"Decreased regional brain metabolism after ECT","volume":"158","author":"MS Nobler","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"12","key":"pone.0226486.ref045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.biopsych.2014.03.029","article-title":"Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression","volume":"76","author":"P Riva-Posse","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"7","key":"pone.0226486.ref046","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biopsych.2012.04.028","article-title":"Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate","volume":"72","author":"MD Fox","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"4","key":"pone.0226486.ref047","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1073\/pnas.042457199","article-title":"Brain activity in ventromedial prefrontal cortex correlates with individual differences in negative affect","volume":"99","author":"DH Zald","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"pone.0226486.ref048","first-page":"1","article-title":"Symbyax: The first medication approved for treatment-resistant depression","volume":"24","author":"LR Epstein","year":"2009","journal-title":"Pharmanote"},{"issue":"10","key":"pone.0226486.ref049","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4088\/JCP.v66n1012","article-title":"Olanzapine\/fluoxetine combination for treatment-resistant depression: A controlled study of SSRI and nortriptyline resistance","volume":"66","author":"RC Shelton","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"pone.0226486.ref050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1176\/appi.ajp.158.1.131","article-title":"A novel augmentation strategy for treating resistant major depression","volume":"158","author":"RC Shelton","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"4","key":"pone.0226486.ref051","first-page":"234","article-title":"Olanzapine and fluoxetine combination in severe or resistant depression","volume":"45","author":"RM Haridas","year":"2003","journal-title":"Indian J Psychiatry"},{"issue":"5","key":"pone.0226486.ref052","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/ern.10.44","article-title":"Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression","volume":"10","author":"WV Bobo","year":"2010","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"pone.0226486.ref053","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4088\/JCP.08m04064","article-title":"An integrated analysis of olanzapine\/fluoxetine combination in clinical trials of treatment-resistant depression","volume":"70","author":"MH Trivedi","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"pone.0226486.ref054","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1038\/npp.2014.101","article-title":"Efficacy and safety of olanzapine\/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder","volume":"39","author":"E Brunner","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"pone.0226486.ref055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2147\/NDT.S127453","article-title":"Efficacy and safety of olanzapine\/fluoxetine combination in the treatment of treatment-resistant depression: A meta-analysis of randomized controlled trials","volume":"13","author":"S Luan","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9","key":"pone.0226486.ref056","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1586\/14737175.8.9.1299","article-title":"Olanzapine\/fluoxetine combination for treatment-resistant depression: Efficacy and clinical utility","volume":"8","author":"S Dodd","year":"2008","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"pone.0226486.ref057","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0893-133X(00)00119-6","article-title":"Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex","volume":"23","author":"W Zhang","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"pone.0226486.ref058","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2003.09.001","article-title":"Brain region and dose effects of an olanzapine\/fluoxetine combination on extracellular monoamine concentrations in the rat","volume":"46","author":"S Koch","year":"2004","journal-title":"Neuropharmacology"},{"issue":"4","key":"pone.0226486.ref059","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/syn.10276","article-title":"Characterization of fluoxetine plus olanzapine treatment in rats: A behavior, endocrine, and immediate-early gene expression analysis","volume":"50","author":"JM Horowitz","year":"2003","journal-title":"Synapse"},{"issue":"8","key":"pone.0226486.ref060","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biopsych.2004.07.008","article-title":"Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat","volume":"56","author":"M Kodama","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"2","key":"pone.0226486.ref061","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2011.04.039","article-title":"Olanzapine plus fluoxetine treatment increases NT-3 protein levels in the rat prefrontal cortex","volume":"497","author":"FR Agostinho","year":"2011","journal-title":"Neurosci Lett"},{"issue":"8","key":"pone.0226486.ref062","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archpsyc.1992.01820080032005","article-title":"The Structured Clinical interview for DSM-III-R (SCID). I: History, rationale, and description","volume":"49","author":"RL Spitzer","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"pone.0226486.ref063","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jalz.2009.09.005","article-title":"Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years","volume":"6","author":"JV Pardo","year":"2010","journal-title":"Alzheimers Dement"},{"key":"pone.0226486.ref064","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV)","author":"MB First","year":"1996"},{"key":"pone.0226486.ref065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"5","key":"pone.0226486.ref066","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0924-9338(98)80032-1","article-title":"Inter-rater reliability of two depression rating scales, MADRS and DRRS, based on videotape records of structured interviews","volume":"13","author":"E Corruble","year":"1998","journal-title":"Eur Psychiatry"},{"key":"pone.0226486.ref067","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-244X-9-26","article-title":"The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder","volume":"9","author":"B Fantino","year":"2009","journal-title":"BMC Psychiatry"},{"issue":"1","key":"pone.0226486.ref068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7547-10-1","article-title":"Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review","volume":"10","author":"EA Zimovetz","year":"2012","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"pone.0226486.ref069","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"M Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"pone.0226486.ref070","volume-title":"ECDEU Assessment Manual For Psychopharmacology","author":"W Guy","year":"1976"},{"issue":"3","key":"pone.0226486.ref071","first-page":"189","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"pone.0226486.ref072","volume-title":"Shipley Institute of Living Scale Revised Manual","author":"RA Zachary","year":"1986"},{"issue":"1","key":"pone.0226486.ref073","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","article-title":"The assessment and analysis of handedness: The Edinburgh inventory","volume":"9","author":"RC Oldfield","year":"1971","journal-title":"Neuropsychologia"},{"key":"pone.0226486.ref074","volume-title":"Manual for the Profile Of Mood States","author":"DM McNair","year":"1971"},{"key":"pone.0226486.ref075","first-page":"644","article-title":"Preliminary manual for the positive affective negative affect schedule","volume":"44","author":"D Watson","year":"1999","journal-title":"J Pers Soc"},{"issue":"9","key":"pone.0226486.ref076","first-page":"1528","article-title":"Anatomic standardization: Linear scaling and nonlinear warping of functional brain images","volume":"35","author":"S Minoshima","year":"1994","journal-title":"J Nucl Med"},{"key":"pone.0226486.ref077","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2342-8-10","article-title":"Internet image viewer (iiv)","volume":"8","author":"JT Lee","year":"2008","journal-title":"BMC Med Imaging"},{"key":"pone.0226486.ref078","volume-title":"Coplanar Stereotaxic Atlas of the Human Brain","author":"J Talairach","year":"1988"},{"issue":"8","key":"pone.0226486.ref079","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S1092852900013754","article-title":"The subgenual cingulate cortex in mood disorde","volume":"13","author":"WC Drevets","year":"2008","journal-title":"CNS Spectr"},{"issue":"3","key":"pone.0226486.ref080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","article-title":"Automated Talairach atlas labels for functional brain mapping","volume":"10","author":"JL Lancaster","year":"2000","journal-title":"Hum Brain Mapp"},{"issue":"Pt 6","key":"pone.0226486.ref081","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/brain\/121.6.1143","article-title":"Aversive gustatory stimulation activates limbic circuits in humans","volume":"121","author":"DH Zald","year":"1998","journal-title":"Brain"},{"issue":"1","key":"pone.0226486.ref082","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1076\/jcen.23.1.121.1223","article-title":"The role of functional neuroimaging in the neuropsyhcology of depression","volume":"23","author":"M Liotti","year":"2001","journal-title":"J Clin Exp Neuropsychol"},{"issue":"12","key":"pone.0226486.ref083","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/da.20435","article-title":"Symptoms of anxiety in depression: Assessment of item performance of the hamilton anxiety rating scale in patients with depression","volume":"25","author":"AL Vaccarino","year":"2008","journal-title":"Depress Anxiety"},{"issue":"7","key":"pone.0226486.ref084","first-page":"1142","article-title":"Cerebral glucose metabolism during pharmacologic studies: Test-retest under placebo conditions","volume":"37","author":"ME Schmidt","year":"1996","journal-title":"J Nucl Med"},{"issue":"1","key":"pone.0226486.ref085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0193(200005)10:1<1::AID-HBM10>3.0.CO;2-O","article-title":"Six-month test-retest reliability of MRI-defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structures","volume":"10","author":"SM Schaefer","year":"2000","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"pone.0226486.ref086","first-page":"269","article-title":"Validation of true low-dose 18F-FDG PET of the brain","volume":"6","author":"D Fallmar","year":"2016","journal-title":"Am J Nucl Med Mol Imaging"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T18:09:43Z","timestamp":1578938983000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226486"}},"subtitle":[],"editor":[{"given":"Tarek K.","family":"Rajji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0226486","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/624288","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]}}}